Bromocriptine for Heart Weakness in Women 18-50
Part of Genetic & congenital, Heart & circulation clinical trials.
This trial tests a medicine called bromocriptine to see if it helps women with a weak heart muscle (dilated cardiomyopathy). It is for women between 18 and 50 whose heart weakness was found recently or is caused by blocked arteries, and who are not pregnant or planning pregnancy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 to 50 years old.
- You have a type of heart muscle weakness (dilated cardiomyopathy) that is either new or caused by blocked heart arteries.
- You do not have other serious heart conditions like valve problems, congenital defects, or high blood pressure-related heart disease.
- You are not pregnant, planning pregnancy, breastfeeding, and have not had heart failure after a past pregnancy.
- Your kidney function is normal (creatinine level below 1.4 mg/dL).
- You have never had a bad reaction to bromocriptine and are willing to take part in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether bromocriptine improves health outcomes in people recently diagnosed with peripartum cardiomyopathy (a weakened heart during late pregnancy or soon after delivery). You may be asked about timing after childbirth, heart strength tests, and whether you plan to keep breastfeeding.
This study tests whether combining aerobic exercise (like walking or cycling) with resistance training (like lifting light weights) can improve heart function and fitness in people with dilated cardiomyopathy, a condition where the heart is enlarged and pumps weakly.
This trial tests a once-daily drug called mexiletine PR to see if it can help reduce muscle stiffness (myotonia) in people with myotonic dystrophy type 1 or 2. It may be a good option if you have a confirmed genetic diagnosis and are at least 16 years old.
This study tests whether the medication amlodipine can help improve symptoms of myotonic dystrophy type 1, particularly hand weakness and slow hand opening. Amlodipine is already used for blood pressure, but it may also affect the muscle problems in DM1.
This study aims to find and treat rare types of heart muscle disease early. If you have heart failure but no known heart disease, researchers will use MRI and other tests to see if a rare cause is behind your symptoms and then offer targeted treatment.
This trial tests how a drug affects heart function in women who have either a low or high body mass index (BMI). It aims to understand cardiovascular health differences across ages and body sizes.
Hear when a new Dilated Cardiomyopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.